TDOC vs AMWL Stock Comparison: AI Score, Valuation, Performance and Upside
Teladoc and American Well both operate in the telehealth industry navigating a post-pandemic demand reset, but Teladoc operates a more direct virtual care service model spanning general medical, mental health, and chronic care, while American Well operates a platform model enabling health systems and payers to deliver their own branded telehealth services.
Teladoc offers exposure to a diversified, direct virtual care service provider with scale advantages, while American Well offers exposure to a platform-based model serving health systems and payers directly. Consider whether you prefer Teladoc's diversified direct care model or American Well's enabling technology platform approach.
TDOC holds the edge across 4 of 5 key metrics in this comparison. AMWL has delivered stronger 1-year price return (+108.89% vs -15.36%), though TDOC has the better forward P/E setup (-8.23x vs -8.78x for AMWL). TDOC leads on both revenue growth (-4.00%) and operating margin (-5.68%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for TDOC (+18.68%) than for AMWL (-7.71%).
Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.
- Want exposure to a diversified virtual care provider spanning general medical, mental health, and chronic care services
- Believe scale advantages support broader service coverage and provider network depth
- Are comfortable with growth rates that have moderated substantially from pandemic-era peaks
- Value established relationships with health plans and employers as a distribution channel
- Prefer a platform-based telehealth model that enables health systems and payers to deliver their own branded services
- Believe continued platform adoption by large healthcare organizations will drive future growth
- Are comfortable with the execution risk inherent in a still-developing path to sustained profitability
- Value a more capital-efficient enabling technology approach over direct care delivery
| Metric | TDOC | AMWL |
|---|---|---|
| AI scorei | 24.8 | 23.6 |
| AI ranki | #3063 | #3669 |
| Latest closei | $6.50 | $13.87 |
| 1M returni | -4.55% | +11.41% |
| 6M returni | +20.59% | +146.36% |
| 1Y returni | -15.36% | +108.89% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | TDOC | AMWL |
|---|---|---|
| 1Y ago | $8.47K (-15.3%) started 2025-09-15 | $21.14K (+111.4%) started 2025-09-15 |
| 5Y ago | $486.09 (-95.1%) started 2021-09-14 | $670.05 (-93.3%) started 2021-09-14 |
| 10Y ago | $3.54K (-64.6%) started 2016-09-14 | $300.61 (-97.0%) started 2020-09-17 |
Hypothetical — past performance does not guarantee future results.
| Metric | TDOC | AMWL |
|---|---|---|
| Market capi | $1.17B | $235.91M |
| Trailing P/Ei | N/A | N/A |
| Forward P/Ei | -8.23 | -8.78 |
| Price/Salesi | N/A | 1.08 |
| EV/Revenuei | 0.56 | 0.26 |
| Analyst targeti | $7.67 | $12.80 |
| Target upsidei | +18.68% | -7.71% |
| Metric | TDOC | AMWL |
|---|---|---|
| Revenue growthi | -4.00% | -26.60% |
| Earnings growthi | N/A | N/A |
| EPS growthi | N/A | N/A |
| FCF margini | +7.67% | +1.77% |
| Operating margini | -5.68% | -19.59% |
| Profit margini | -7.13% | -35.75% |
| ROIC proxyi | -12.98% | -29.12% |
| Return on equityi | -12.98% | -29.12% |
| Dividend yieldi | N/A | 0.00% |
| Payout ratioi | 0.00% | 0.00% |
| Dividend growth streaki | N/A | N/A |
| Betai | 2.13 | 1.71 |
| Debt/equityi | 79.09 | 1.27 |
| Current ratioi | 0.83 | 2.90 |
| Quick ratioi | 0.73 | 2.72 |
Over the past year, TDOC and AMWL have moved weakly in the same direction (correlation of 0.37), based on daily returns.
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | TDOC | AMWL |
|---|---|---|---|
| 1Y | Growthi | -15.25% | +111.43% |
| CAGRi | -15.30% | +111.98% | |
| Volatilityi | 64.04% | 70.96% | |
| Sharpe ratioi | 0.00 | 1.34 | |
| Sortino ratioi | 0.00 | 2.53 | |
| Max drawdowni | 52.75% | 42.38% | |
| Current drawdowni | 33.13% | 0.00% | |
| Avg drawdowni | 25.88% | 15.98% | |
| Ulcer Indexi | 29.83% | 19.79% | |
| Max daily dropi | 28.32% | 10.50% | |
| Max wkly dropi | 28.31% | 22.77% | |
| 5Y | Growthi | -95.14% | -93.30% |
| CAGRi | -45.39% | -41.76% | |
| Volatilityi | 65.60% | 78.57% | |
| Sharpe ratioi | -0.66 | -0.37 | |
| Sortino ratioi | -0.90 | -0.57 | |
| Max drawdowni | 97.10% | 98.32% | |
| Current drawdowni | 95.79% | 93.84% | |
| Avg drawdowni | 83.01% | 82.63% | |
| Ulcer Indexi | 85.41% | 84.85% | |
| Max daily dropi | 40.15% | 23.08% | |
| Max wkly dropi | 43.25% | 38.27% | |
| 10Y | Growthi | -64.60% | -96.99% |
| CAGRi | -9.86% | -44.29% | |
| Volatilityi | 60.79% | 78.63% | |
| Sharpe ratioi | 0.06 | -0.42 | |
| Sortino ratioi | 0.09 | -0.64 | |
| Max drawdowni | 98.48% | 99.56% | |
| Current drawdowni | 97.79% | 98.38% | |
| Avg drawdowni | 53.59% | 87.38% | |
| Ulcer Indexi | 66.67% | 89.90% | |
| Max daily dropi | 40.15% | 23.08% | |
| Max wkly dropi | 43.25% | 38.27% |
| Category | TDOC | AMWL |
|---|---|---|
| Company | Teladoc Health, Inc. | American Well Corporation |
| Sector | Healthcare | Healthcare IT |
| Industry | Health Information Services | Health Information Services |
| Core business | A virtual care company providing telehealth services including general medical consultations, mental health support, and chronic condition management through a technology platform serving individual, employer, and health plan customers. | A telehealth technology company providing a virtual care platform that enables health systems, health plans, and other healthcare organizations to deliver their own branded telehealth services to patients. |
| Investor focus | Mental health and chronic care segment growth, membership and utilization trends, and progress toward sustained profitability following the post-pandemic demand normalization. | Platform adoption by health system and health plan customers, revenue growth trajectory, and progress toward improved cash flow and profitability. |
- Diversified service offering spans general medical, mental health, and chronic condition management virtual care
- Established relationships with health plans and employers provide a distribution channel for telehealth services
- Scale as one of the largest telehealth providers supports broader service coverage and provider network depth
- Platform-based business model enables healthcare organizations to deliver telehealth under their own brand, differentiating from direct-to-consumer competitors
- Partnerships with large health systems and payers provide access to established patient populations
- Focus on enabling technology rather than direct care delivery allows for a more capital-efficient scaling approach
- Growth rates have moderated substantially from pandemic-era peaks, requiring new demand drivers to reaccelerate
- Path to consistent profitability has required ongoing cost discipline and business model adjustments
- Competitive telehealth landscape includes both dedicated virtual care companies and traditional healthcare providers building their own offerings
- Revenue growth has faced pressure as post-pandemic telehealth demand normalized from earlier elevated levels
- Profitability path requires continued platform adoption growth and disciplined cost management
- Smaller scale relative to larger telehealth competitors limits some negotiating leverage with large customers
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.